Skip to main content

Modelling the impact of social protection on tuberculosis: the S-PROTECT project

Abstract

Background

Tackling the social determinants of Tuberculosis (TB) through social protection is a key element of the post-2015 End TB Strategy. However, evidence informing policies are still scarce. Mathematical modelling has the potential to contribute to fill this knowledge gap, but existing models are inadequate. The S-PROTECT consortium aimed to develop an innovative mathematical modelling approach to better understand the role of social protection to improve TB care, prevention and control.

Methods

S-PROTECT used a three-steps approach: 1) the development of a conceptual framework; 2) the extraction from this framework of three high-priority mechanistic pathways amenable for modelling; 3) the development of a revised version of a standard TB transmission model able to capture the structure of these pathways. As a test case we used the Bolsa Familia Programme (BFP), the Brazilian conditional cash transfer scheme.

Results

Assessing one of these pathways, we estimated that BFP can reduce TB prevalence by 4% by improving households income and thus their nutritional status. When looking at the direct impact via malnutrition (not income mediated) the impact was 33%. This variation was due to limited data availability, uncertainties on data transformation and the pathway approach taken. These results are preliminary and only aim to serve as illustrative example of the methodological challenges encountered in this first modelling attempt, nonetheless they suggest the potential added value of integrating TB standard of care with social protection strategies.

Conclusions

Results are to be confirmed with further analysis. However, by developing a generalizable modelling framework, S-PROTECT proved that the modelling of social protection is complex, but doable and allowed to draw the research road map for the future in this field.

Peer Review reports

Background

The End TB Strategy has placed TB within the new sustainable development agenda [1] under which health and development are considered to be profoundly interlinked. No sustainable health or development goal can be achieved without a truly multisectoral approach. The alignment between the End TB Strategy and the SDGs is reflected both in this underlying philosophy, as well as the proposed targets and strategies. Social protection, which sits at the intersection between health and social interventions, can contribute to both poverty elimination and important health goals, include the goal to End TB [2].

Social protection has been defined as a wide range of policies to move people out of extreme poverty and achieve sustainable inclusion and economic growth [3]. Among them, cash transfers interventions (CTIs), whether conditional or unconditional, have become some of the most popular forms of social protection approaches [4] and they are also the main focus of this paper.

CTIs are increasingly regarded as a potentially powerful tool to enhance TB prevention (by allowing better resilience to TB infection and disease that result from improved material living conditions); TB care (by enabling better and more timely access to quality TB care); and TB support (by mitigating the TB-related catastrophic costs) [5]. Evidence to support this postulated impact are slowly accumulating [6,7,8,9,10,11,12]; however the existing knowledge base is still insufficient to derive conclusions about the quantitative impact of CTIs on TB and the mechanisms through which this impact is likely to happen. While randomised trials would be the gold standard for answering these questions, they can be complex, expensive, lengthy, and potentially unethical. Mathematical models could play an important role in filling these knowledge gaps. Unfortunately few modelling exercises have explored the degree to which socioeconomic interventions affect TB risks, and to which social protection interventions can reduce TB burden by modifying these determinants [13, 14]. This situation largely reflects the challenges of assembling the interdisciplinary teams necessary to construct such models and of describing the complex web of causal factors through which CTIs might impact TB burden and distribution using quantitative terms [15]. Although several conceptual frameworks have been developed to describe these mechanisms [16], these frameworks have rarely been tested with epidemiological studies to construct mathematical models. Furthermore, the quality and accessibility of epidemiological data linking TB epidemiologic data and social protection in general is often sparse. Thus, while the potential effect of CTIs on TB control is deemed potentially large, quantifying that effect in the context of a tractable model may be challenging.

The S-PROTECT (Social PROTection to Enhance the Control of Tuberculosis) consortium was created to respond to these challenges: we developed a combined conceptual-quantitative modelling framework through which existing empirical data could be used to inform estimates of the effect of CTIs on TB control. Importantly, in this paper we do not attempt to reach conclusions on the impact of CTIs on TB; rather, we illustrate methodological steps during the first 12 months of the project and highlight the strengths and limitations of the approach taken by presenting some preliminary mathematical modelling findings. We conclude by discussing the main challenges encountered and how they can inform the future research agenda on social protection modelling.

Methods

The S-PROTECT conceptual framework

The S-PROTECT Modelling Consortium aimed to bring together an interdisciplinary team of experts (including mathematical modellers, social epidemiologists, decision-makers, and local implementers) to develop a mathematical model able to capture the various processes through which CTIs may influence TB epidemiology and control. Critical steps in the development of this tool included: a) advancing a theory-based conceptual framework describing the mechanism through which social protection might affect TB outcomes and then translating this conceptual framework into a simplified version suitable for modelling purposes; b) using a modified Delphi process to rank mechanistic pathways within this conceptual framework that would be most suitable for incorporation into a mathematical model. c) developing a mathematical model best reflecting the structure of these pathways. We used as a test case Bolsa Familia Programme (BFP), the Brazilian national conditional cash transfer programme (Table 1).

Table 1 The Bolsa Familia Programme (BFP) [30]

The conceptual underpinning

The underlying conceptual framework used by S-PROTECT was adapted from Boccia et al. [17] This framework (Fig. 1) attempts to map the pathway through which social protection may have an influence on the various stages of TB natural history.

Fig. 1
figure 1

Conceptual framework: the original version and the quantitative translation into 13 separate pathways. In its original version (Fig. 1a) this framework assumes that social protection interventions such as the Bolsa Familia Programme can improve TB outcomes either indirectly by influencing the distal/structural social determinants of TB (e.g., living conditions, food security), or directly by making support conditional on health-seeking behaviours relevant for TB (e.g. TB testing and preventive therapy among household contacts, TB treatment completion, BCG vaccination in children). Indirect effects on distal social determinants can alter a number of proximal mediators (e.g., indoor air pollution, malnutrition, co-morbidities) known to be associated with TB infection, progression, disease severity, or TB outcomes (including economic impact, albeit this was not accounted for in this initial modelling effort). To the extent that these associations are causal, and depending of the population targeted, reducing the prevalence of these mediators should improve TB outcomes accordingly. Fig 1b represents graphically the quantitatively derived version of this framework outlining the 13 pathways that were prioritised and extracted specifically for Bolsa Familia in Brazil. As explained in the text, three levels of impact can be identified (outlined at the top of figure: 1) the impact of social protection on distal factors (e.g. household socioeconomic position); 2) the impact of distal factors on more proximal social determinants of TB (i.e. listed from 1 to 13 depending on the specific pathway); and 3) the impact of these factors on TB outcomes (e.g. infection or disease). When social protection schemes are developed to have direct effects on TB outcomes themselves (e.g. in TB-specific interventions),(HYPERLINK "" \l "_ENREF_17" \o "Boccia, 2016 #1990" 17) the first two levels (1 and 2) can be bypassed; however, in the much more common situation where social protection is designed at programmatic level (like BFP) to improve the distal structural determinants of health, all three levels must be considered

Within this framework three distinct levels of impact can be distinguished:

Level 1 - Impact of social protection on distal factors/structural determinants of health [18].

Level 2 - Impact of distal factors on proximal mediators/social determinants of TB [18].

Level 3 - Impact of proximal mediators on TB outcomes.

Prioritizing the mechanistic pathways

In order to incorporate the above levels of effect into a quantitative model, we used the tool of mechanistic pathways. Specifically, through a consensus review process, the S-PROTECT team first brainstormed and then prioritised a set of pathways that were consistent with the original conceptual framework but that could be quantified at each of the three levels of effect. Figure 1b and Table 2 show 13 pathways - an illustrative rather than comprehensive list. Each mechanistic pathway can be conceptualised as a quantitative adaptation of a component of the framework in Fig. 1; if the entirety of these pathways and their overlap could be identified and quantified, then the full effect of social protection on TB outcomes (except for financial outcomes) could be estimated. Since this is not possible, we decided instead to prioritise individual pathways for further investigation, understanding that we are thereby excluding the effects of non-prioritised pathways, as well as any synergies (or antagonism) between individual pathways when those pathways are realised together.

Table 2 Pathways extracted from the conceptual framework and pathways rankinga

In prioritizing among the 13 pathways for further exploration with the modelling framework, we used two criteria: (1) importance from the perspective of the likely effect of the pathway on the epidemiology of TB (and specifically in Brazil); and (2) measurability in terms of whether data (whether from the published literature or from publicly available sources) might currently exist to inform quantitative estimates of association at each level of the pathway. Pathways were ranked as either low, medium, or high priority. Differences between team members were resolved by consensus, resulting in the ranking displayed in Table 2.

Through this process three priority pathways were identified: pathways #10, #11 and #12 (Table 2). These three high priority pathways were populated with evidence obtained from three sources of data: a) published effect estimates from the literature; b) de novo analysis of publicly available data; and when no other estimate could be identified, c) assumptions made by experts in the field of social protection and TB. The data collection and synthesis approach as well as data assumptions are described respectively in the online Additional file 1: Appendix 1 and 2.

Pathway #10, was then further developed for inclusion into the quantitative modelling framework (Table 3 and Table 4).

Table 3 Measures of impact for pathway #10
Table 4 Challenges encountered during S-PROTECT and research roadmap

The model development

We conceptualised our modelling approach to capture the impact of CTIs – and BFP in particular - on TB in two parts. In the first part, we aimed to estimate the impact of CTIs like BFP on each of the proximal mediators of TB outcomes. This was achieved by first estimating the effects at each of the three levels of a given pathway separately based on the literature review, and then combining them together. In the second part, we aimed to estimate the impact of change in any of the proximal mediators of TB outcomes on the overall TB prevalence. To achieve this, we formulated a simple model of TB transmission and natural history, which factored in each of the proximal mediators of TB outcomes to generate estimates of TB prevalence.

The complete mathematical description of the model, along with the parameters used to calibrate the model and a schematic representation of the model are presented in Additional file 2 (see online Additional file 1: Appendix 3 to see how pathway # is expected to affect the model parameters estimates).

Results

Based on the secondary data drawn from the literature and our assumptions we estimated that the impact of BFP on the proximal mediators of TB outcomes as mediated via pathway #10 alone to be generally modest. For example, we estimated that BFP would improve TB treatment success by 1.5% (0.28, 4.77%), time to TB diagnosis by 0.12% (0.04, 0.59%), and TB transmission rates (measured as TB incidence) by 1.33% (0.48, 2.89%). The overall modest impact reflected both relatively low increase in household income achieved via CTIs like BFP (15% increase) and low effect of income on nutrition (0.129 increase in BMI per US$1000 increase in household income). The large range in estimates generally reflected uncertainty in data, such as the estimates of BFP driven changes in household income, and the impact of improved nutrition on the proximal mediators of TB outcomes.

We then estimated the change in TB prevalence induced by the changes in each of the proximal mediators of TB outcomes by the quantities estimated above. The change in TB prevalence was calculated with the transmission model at its respective equilibrium, before and after the change, hence providing an estimate for a long-term change. For example, for reduction achieved via pathway #10, we estimated an overall long-term reduction in TB prevalence by 3.9% (low: 0.7%, high: 23.5%). Of this, 1.9% (0.1, 14.0%) reduction was achieved via improved TB treatment success alone, 0.7% (0.1, 6.8%) by reduction in time to treatment alone and, 1.3% (0.5, 2.9%) achieved via reduction in disease susceptibility alone.

We also sought to estimate the direct impact of BFP without restricting the impact to be mediated via effect on income. Using an estimated impact of BFP-equivalent in Mexico on nutrition (which estimated a 0.83 units increase in BMI [19], we then proceeded to estimate the impact on each of the proximal mediators of TB outcomes, and used the same model to estimate the impact on TB prevalence. We estimated an impact of 32.1% reduction in TB prevalence via this direct measure, almost 10 times larger than our estimates from pathways driven by income only (Additional file 2).

Discussion

The S-PROTECT project has contributed to the increasing bulk of evidence on the impact of CTIs on TB epidemiology and control. Most importantly, it allowed the identification of a number of both conceptual and methodological challenges that must be addressed in future mathematical modelling if we are to successfully develop estimates of the impact of CTIs - and social protection in general - on TB elimination efforts.

These challenges are outlined below and summarised in Table 4. For each of them we also propose a research road map.

Study population

It is critical to specify the population under study. Most CTIs apply very stringent criteria to target their beneficiaries, based on poverty-related criteria both at household and community level. This target population is often people living in extreme poverty at highest risk of TB disease, but individuals who qualify for CTIs intermingle with people who do not (“general population”) in ways that are very challenging to understand and quantify. Furthermore, the relative size of the target population, as well as the relative prevalence of TB in this population (both compared to the general population) is often poorly defined and mainly available from a limited number of prevalence surveys that have collected socioeconomic data [20, 21]. It is impossible to quantitatively estimate the impact of a given CTIs intervention on TB epidemiology in a general population without specifying (through data or assumption) three quantities: (a) size of the target population (as a proportion of the total population); (b) relative TB burden in the target population (versus the general population); and (c) degree mixing dynamics between members of the target and general population. With S-PROTECT we tried to circumvent these concerns by focusing a modelling effort on the CTI target population alone (i.e. the people eligible for BFP) and effectively assuming no interplay with the general population. With this assumption we challenged the conventional idea of TB incidence “hotspots” defined geographically and replaced it with the notion of hotspots defined by high risk groups bearing the highest burden of disease in a given community. This assumption was deemed legitimate for Brazil, where the epidemic of TB is highly concentrated in some high-risk groups [22], but this approach may be less appropriate in other settings. Nonetheless, it is plausible to think that by intervening in the highest-risk populations (who may generate the majority of TB transmission), ending TB also in the general population may be achieved effectively [23, 24].

Data availability and harmonisation

Despite the abundant evidence on the impact of CTIs and the vast literature on TB, it was challenging to identify and bring together the necessary evidence for each level of the studied high priority pathways. This was partially due to the fact that we aimed to link data extrapolated from different types of sources and also different levels of analysis and partially because there is currently no consensus regarding how to convert outcomes and units of measure even when they are available. For example, studies that estimate associations between CTIs and structural determinants of health (“level 1”) often use different outcomes than those that study associations between structural determinants of health and proximal mediators of TB (“level 2”) or between those proximal mediators and TB outcomes (“level 3”). Specifically, for Pathway #10, we found that “level 1” studies estimated the impact of CTIs on household SES as a percent change in monthly income or expenditure whilst many “level 2” studies estimated the association between SES and malnutrition, with SES measured as a dichotomous variable (i.e., above or below an income threshold). In this case, to estimate the effect of CTIs on malnutrition via income it would have been necessary to further assume the relationship between a percent increase in income/expenditure crossing the “level 2” studies’ income thresholds. Similarly, whilst most “level 2” studies used a continuous increase in BMI as the dependent outcome, most “level 3” studies used WHO BMI weight categories (< 18.5, 18.5 to 24.9 and > 25) as independent determinants of TB outcomes, thereby requiring two conversion steps to estimate the quantitative impact of social protection on TB outcomes, and a third conversion if the “level 3” outcome did not precisely correspond to a specific parameter in the model. This conversion is even more challenging when the “linking” outcome measures themselves (i.e., monthly expenditure and BMI in the example of Pathway #10 are incongruous.

Understanding pathways

S-PROTECT aimed to contribute to the understanding of the mechanism through which CTIs act on TB prevention and clinical outcomes; however, as demonstrated this pathway approach may lead to an underestimate of the ultimate impact if the effect is somehow diluted across levels and/or the biggest impact happens at the bottom of the tail. Furthermore, it is unlikely that 13 pathways identified in S-PROTECT were able to capture the full effect. CTIs are likely to improve characteristics of the population in ways that are difficult to analytically define, and these improvements may have important effects on TB dynamics. It is also very likely that the prioritisation exercise we attempted for Brazil may return a different ranking of pathways in a different study setting. Furthermore, study generalisability may be only limited to countries within the Latin American region where social protection programs similar to BFP operate. Nonetheless, generalisability of findings was not a key goal in this stage of the SPROTECT project, whose main scope was indeed the development and testing of a generic mathematical modelling approach that could be adopted and adapted for other settings despite the context-specific pathways ranking and impact findings. Furthermore, TB inequalities have been typically explained using a material/neo-material lens [25], by which TB happens mainly because of the exposure to inadequate material living conditions (i.e. poor housing quality, insufficient or bad quality food consumption, dangerous working conditions, etc) [16]. This was the approach taken by S-PROTECT too; however it is indeed plausible that alternative aetiological models such as the psychosocial [26] or life course approach [27, 28] could also help to explain the marked TB gradient across socioeconomic strata and consequently provide further explanation of TB inequalities are established, perpetrated and can be mitigated. This is also clearly expressed in the theory of fundamental causes of health inequalities proposed by Link and Phelan [29], according to which multiple pathways need to be tested and blocked to achieve a detectable impact at population level.

Conclusions

To our knowledge the S-PROTECT project is the first attempt to use mathematical modelling to predict the impact social protection interventions, such as the BFP, on indicators of TB prevention, care and control.

The modest estimates of impact on TB prevalence are just illustrative, but reflect generally the low impact of BFP on the proximal mediators of TB, and the consequences of restricting ourselves to estimating the impact via narrowly defined pathways. Furthermore, we may have underestimated the true effect by not accounting for heterogeneity of impact across different groups (i.e. extremely poor household), by assuming an homogenous distributions of TB patients as well as a linear relationship between BFP vs income and income vs nutrition and nutrition vs TB indicators. While these are important limitations worth to be addressed in future analysis, our primary purpose for this paper was to develop a generalizable framework, not to develop exact or comprehensive estimates of BFP impact on TB in Brazil.

The approach we have adopted was helpful to improve our quantitative understanding of the linkages between social protection and TB burden, highlight key gaps in both data and aetiological pathway thinking, and prioritise efforts for data collection and transformation. These emerged lessons will inform the next phase of S-PROTECT, through which we aim to refine our methodological approaches (including impact heterogeneity), expand our focus beyond CTIs (i.e. employment protection and/or housing and slum upgrading interventions) and to develop a more sophisticate, yet still amenable for mathematical modelling, conceptual framework encompassing a life-course approach and accounting also for psychosocial factors. However, for the time being S-PROTECT proved that by combining different expertise, it is indeed possible to model the impact of social protection on TB prevention, care and control with existing knowledge and analytical tools.

Abbreviations

BFP :

Bolsa Familia Programme

BMI:

Body Mass Index

CTI:

Cash Transfer Intervention

S-PROTECT:

Social Protection to Enhance the Control of Tuberculosis

TB:

Tuberculosis

WHO:

World Health Organization

References

  1. Lonnroth K, Raviglione M. The WHO's new end TB strategy in the post-2015 era of the sustainable development goals. Trans R Soc Trop Med Hyg. 2016;110(3):148–50.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's new end TB strategy. Lancet. 2015;385(9979):1799–801.

    Article  PubMed  Google Scholar 

  3. Devereux S, Sabates-Wheeler R. Transformative social protection. IDS working paper N. 232. Brighton: Institute of Development Studies, University of Sussex; 2004.

    Google Scholar 

  4. Honorati M, Gentilini U, Yemtsov RG. The state of social safety nets 2015 (English). Washington, D.C: World Bank Group; 2015. http://documents.worldbank.org/curated/en/415491467994645020/The-state-of-social-safety-nets-2015.

  5. Boccia D, Hargreaves JR, Lonnroth K, Jaramillo E, Uplekar M, Porter JDH, et al. Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. Int J Tuberc Lung Dis. 2011;15(Supplement 2):S37–49.

    Article  PubMed Central  Google Scholar 

  6. Torrens AW, Rasella D, Boccia D, Maciel EL, Nery JS, Olson ZD, et al. Effectiveness of a conditional cash transfer programme on TB cure rate: a retrospective cohort study in Brazil. Trans R Soc Trop Med Hyg. 2016;110(3):199–206.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, et al. A novel socioeconomic intervention improves TB cure and chemoprophylaxis completion in Peruvian shantytowns: a randomized controlled evaluation. 46th union word conference on lung health, union/CDC late-breaker session on TB; cape town, South Africa 2015.

    Google Scholar 

  8. Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, et al. The economic effects of supporting tuberculosis-affected households in Peru. Eur Respir J. 2016;48(5):1396–410.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Siroka A, Ponce NA, Lonnroth K. Association between spending on social protection and tuberculosis burden: a global analysis. Lancet Infect Dis. 2015.

  10. Reeves A, Basu S, McKee M, Stuckler D, Sandgren A, Semenza J. Social protection and tuberculosis control in 21 European countries, 1995-2012: a cross-national statistical modelling analysis. Lancet Infect Dis. 2014;14(11):1105–12.

    Article  PubMed  Google Scholar 

  11. Ciobanu A, Domente L, Soltan V, Bivol S, Severin L, Plesca V, et al. Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova? Public Health Action. 2014;4(Suppl 2):S59–63.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Sripad A, Castedo J, Danford N, Zaha R, Freile C. Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18(1):44–8.

    Article  PubMed  CAS  Google Scholar 

  13. Murray M, Oxlade O, Lin HH. Modeling social, environmental and biological determinants of tuberculosis. Int J Tuberc Lung Dis. 2011;15(Suppl 2):S64–70.

    Article  Google Scholar 

  14. Oxlade O, Huang CC, Murray M. Estimating the impact of reducing under-nutrition on the tuberculosis epidemic in the central eastern states of India: a dynamic modeling study. PLoS One. 2015;10(6):e0128187.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Dye C, Raviglione M. Perspective: weigh all TB risks. Nature. 2013;502(7470):S13.

    Article  PubMed  CAS  Google Scholar 

  16. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101:654–62.

  17. Boccia D, Pedrazzoli D, Wingfield T, Jaramillo E, Lonnroth K, Lewis J, et al. Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities. BMC Infect Dis. 2016;16:307.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Solar O, Irwin A. A conceptual framework for action on the social determinants of health. Social Determinants of Health Discussion Paper 2 (Policy and Practice). Geneva: World Health Organization; 2010.

  19. Fernald LC, Gertler PJ, Neufeld LM. Role of cash in conditional cash transfer programmes for child health, growth, and development: an analysis of Mexico's Oportunidades. Lancet. 2008;371(9615):828–37.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kapata N, Chanda-Kapata P, Ngosa W, Metitiri M, Klinkenberg E, Kalisvaart N, et al. The prevalence of tuberculosis in Zambia: results from the first national TB prevalence survey, 2013-2014. PLoS One. 2016;11(1):e0146392.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Hoa NB, Tiemersma EW, Sy DN, Nhung NV, Gebhard A, Borgdorff MW, et al. Household expenditure and tuberculosis prevalence in Viet Nam: prediction by a set of indicators. Int J Tuberc Lung Dis. 2010;15(1):32–7.

    Google Scholar 

  22. Maciel EL, Pan W, Dietze R, Peres RL, Vinhas SA, Ribeiro FK, et al. Spatial patterns of pulmonary tuberculosis incidence and their relationship to socio-economic status in Vitoria, Brazil. Int J Tuberc Lung Dis. 2010;14(11):1395–402.

    PubMed  PubMed Central  CAS  Google Scholar 

  23. Andrews JR, Basu S, Dowdy DW, Murray MB. The epidemiological advantage of preferential targeting of tuberculosis control at the poor. Int J Tuberc Lung Dis. 2015;19(4):375–80.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Dowdy DW, Golub JE, Chaisson RE, Saraceni V. Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics. Proc Natl Acad Sci U S A. 2012;109(24):9557–62.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Harling G, Ehrlich R, Myer L. The social epidemiology of tuberculosis in South Africa: a multilevel analysis. Soc Sci Med. 2008;66(2):492–505.

    Article  PubMed  Google Scholar 

  26. Falagas ME, Karamanidou C, Kastoris AC, Karlis G, Rafailidis PI. Psychosocial factors and susceptibility to or outcome of acute respiratory tract infections. Int J Tuberc Lung Dis. 2010;14(2):141–8.

    PubMed  CAS  Google Scholar 

  27. Kritchevsky SB. Commentary: Connections across life stages and disease risk: commentary on a study early in the life course of life course epidemiology. Int J Epidemiol. 2016;45(4):1036–9.

    PubMed  Google Scholar 

  28. Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol. 2002;31(2):285–93.

    Article  PubMed  Google Scholar 

  29. Phelan JC, Link BG, Tehranifar P. Social conditions as fundamental causes of health inequalities: theory, evidence, and policy implications. J Health Soc Behav. 2010;51(Suppl):S28–40.

    Article  PubMed  Google Scholar 

  30. Soares TS. Bolsa Familia, its design, its impact and possibilities for the future. Working paper Number 89. Brazilia, Brazil: International Policy Centre for Inclusive Growth; 2012 [Available from: http://www.ipc-undp.org/pub/IPCWorkingPaper89.pdf.

  31. Attanasio O, Battistin E, Mesnard A. Food and Cash transfers: evidence from Colombia. Econ J. 2012;122(559):92–124.

    Article  Google Scholar 

  32. Perova E, Vakis R. 5 years in Juntos: new evidence on the Program’s short and long-term impacts. Economia. 2012;35(69):53–82.

    Google Scholar 

  33. Ward J, Friche AA, Caiaffa WT, Proietti FA, Xavier CC, Roux AV. Association of socioeconomic factors with body mass index, obesity, physical activity, and dietary factors in Belo Horizonte, Minas Gerais state, Brazil: the BH health study. Cad Saude Publica. 2015;31(Suppl 1):182–94.

    Article  PubMed  Google Scholar 

  34. Colchero MA, Sosa-Rubi SG. Heterogeneity of income and lifestyle determinants of body weight among adult women in Mexico, 2006. Soc Sci Med. 2012;75(1):120–8.

    Article  PubMed  CAS  Google Scholar 

  35. Almeida CP, Skupien EC, Silva DR. Health care seeking behavior and patient delay in tuberculosis diagnosis. Cad Saude Publica. 2015;31(2):321–30.

    Article  PubMed  Google Scholar 

  36. Maciel EL, Golub JE, Peres RL, Hadad DJ, Favero JL, Molino LP, et al. Delay in diagnosis of pulmonary tuberculosis at a primary health clinic in Vitoria, Brazil. Int J Tuberc Lung Dis. 2010;14(11):1403–10.

    PubMed  PubMed Central  CAS  Google Scholar 

  37. Bernabe-Ortiz A. Factors associated with survival of patients with tuberculosis in Lima, Peru. Rev Chilena de Infectol. 2008;25(2):104–7.

    Article  Google Scholar 

  38. Lonnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39(1):149–55.

    Article  PubMed  Google Scholar 

  39. Kabeer N, Waddington H. Economic impacts of conditional cash transfer programmes: a systematic review and meta-analysis. J Dev Eff. 2015;7(3):290–303.

    Article  Google Scholar 

  40. Bhaskaram P. Micronutrient malnutrition, infection, and immunity: an overview. Nutr Rev. 2002;60(5 Pt 2):S40–5.

    Article  PubMed  Google Scholar 

  41. Vynnycky E, Fine PE. Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol. 2000;152(3):247–63.

    Article  PubMed  CAS  Google Scholar 

  42. Huynh GH, Klein DJ, Chin DP, Wagner BG, Eckhoff PA, Liu R, et al. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med. 2015;13:88.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was funded by the TB Modelling and Analysis Consortium (Bill and Melinda Gates Foundation, OPP1084276. Delia Boccia was funded by the Wellcome Trust (104473/7/14/Z).

Availability of data and materials

The data that support the findings of this study are available from published literature as available in the references section of the paper.

Author information

Authors and Affiliations

Authors

Contributions

DB, WR, SS, KL, PE, JG, MS, EM, DR, PS, DB, RH, SC, and DD agreed on the study protocol and contributed together to the conceptual and methodological steps taken during the S-PROTECT project. DB, DD, SS, and WR were involved in the literature search, data extraction and actual data modelling. DB drafted the version of the paper and all authors commented and revised the draft until its final version. All authors read and approved the final manuscript.

Corresponding author

Correspondence to D. Boccia.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional files

Additional file 1:

Appendix 1. Data review strategy. Appendix 2. Assumptions for pathway #10. Appendix 3. Model parameters affected by Pathway #10. (PDF 461 kb)

Additional file 2:

A) Model development and B) Illustrative example of Bolsa Familia Programme (BFP) impact estimates for pathway #10. (DOCX 112 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boccia, D., Rudgard, W., Shrestha, S. et al. Modelling the impact of social protection on tuberculosis: the S-PROTECT project. BMC Public Health 18, 786 (2018). https://doi.org/10.1186/s12889-018-5539-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-018-5539-x

Keywords